Prostate-specific membrane antigen: Present and future application

被引：28

作者：

Chang, SS

Gaudin, PB

Reuter, VE

Heston, WDW

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Urol, New York, NY 10021 USA

[2] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA

来源：

UROLOGY | 2000年 / 55卷 / 05期

关键词：

D O I：

10.1016/S0090-4295(99)00600-7

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：622 / 629

页数：8

共 57 条

[1]

Amling C L, 1997, Semin Urol Oncol, V15, P222

[2] RADIOIMMUNOSCINTIGRAPHY OF PELVIC LYMPH-NODES WITH (111)INDIUM-LABELED MONOCLONAL-ANTIBODY CYT-356 [J].

BABAIAN, RJ ;

SAYER, J ;

PODOLOFF, DA ;

STEELHAMMER, LC ;

BHADKAMKAR, VA ;

GULFO, JV .

JOURNAL OF UROLOGY, 1994, 152 (06) :1952-1955

[3]

Bostwick DG, 1998, CANCER-AM CANCER SOC, V82, P2256, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2256::AID-CNCR22>3.0.CO

[4]

2-S

[5] Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase [J].

Carter, RE ;

Feldman, AR ;

Coyle, JT .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (02) :749-753

[6]

CARTER RE, 1998, J PHARMACOL EXP THER, V28, P1020

[7]

Chang S. S., 1999, Proceedings of the American Association for Cancer Research Annual Meeting, V40, P489

[8]

Chang SS, 1999, CANCER RES, V59, P3192

[9]

Chengazi VU, 1997, J NUCL MED, V38, P675

[10]

Diamond Stuart M., 1995, Journal of Urology, V153, p382A

← 1 2 3 4 5 6 →